Publicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (24)

2023

  1. Prevalence, incidence and risk factors for acquisition and colonization of extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae from dogs attended at a veterinary hospital in Spain

    Comparative Immunology, Microbiology and Infectious Diseases, Vol. 92

2019

  1. Microcins in Enterobacteriaceae: Peptide Antimicrobials in the Eco-Active Intestinal Chemosphere

    Frontiers in Microbiology, Vol. 10

2018

  1. PCR-based analysis of ColE1 plasmids in clinical isolates and metagenomic samples reveals their importance as gene capture platforms

    Frontiers in Microbiology, Vol. 9, Núm. MAR

2014

  1. Recombination blurs phylogenetic groups routine assignment in Escherichia coli: Setting the record straight

    PLoS ONE, Vol. 9, Núm. 8

2010

  1. Polymorphic mutation frequencies of clinical and environmental Stenotrophomonas maltophilia populations

    Applied and Environmental Microbiology, Vol. 76, Núm. 6, pp. 1746-1758

2008

  1. Prevalencia de infecciones por Acinetobacter baumannii resistente a carbapenemas en España (1999-2005)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 4, pp. 199-204

  2. The evolution of contact-dependent inhibition in non-growing populations of Escherichia coli

    Proceedings of the Royal Society B: Biological Sciences, Vol. 275, Núm. 1630, pp. 3-10

2007

  1. Mutation rate is reduced by increased dosage of mutL gene in Escherichia coli K-12

    FEMS Microbiology Letters, Vol. 275, Núm. 2, pp. 263-269

2006

  1. Plitidepsin cellular binding and Rac1/JNK pathway activation depend on membrane cholesterol content

    Molecular Pharmacology, Vol. 70, Núm. 5, pp. 1654-1663

2005

  1. Increased mutation frequencies in Escherichia coli isolates harboring extended-spectrum β-lactamases

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 11, pp. 4754-4756

  2. SOS-independent induction of dinB transcription by β-lactam-mediated inhibition of cell wall synthesis in Escherichia coli

    Journal of Bacteriology, Vol. 187, Núm. 4, pp. 1515-1518

2004

  1. Fosfomycin and rifampin disk diffusion tests for detection of Escherichia coli mutator strains

    Journal of Clinical Microbiology, Vol. 42, Núm. 9, pp. 4310-4312

  2. Polymorphic mutation frequencies in Escherichia coli: Emergence of weak mutators in clinical isolates

    Journal of Bacteriology, Vol. 186, Núm. 16, pp. 5538-5542

2003

  1. Erratum: Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation (Antimicrobial Agents and Chemotherapy (2003) 47:4 (1464-1467))

    Antimicrobial Agents and Chemotherapy

  2. Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation

    Antimicrobial Agents and Chemotherapy, Vol. 47, Núm. 4, pp. 1464-1467

  3. Haemophilus influenzae blaROB-1 mutations in hypermutagenic ΔampC Escherichia coli conferring resistance to cefotaxime and β-lactamase inhibitors and increased susceptibility to cefaclor

    Antimicrobial Agents and Chemotherapy, Vol. 47, Núm. 8, pp. 2551-2557

  4. The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IronN

    Microbiology, Vol. 149, Núm. 9, pp. 2557-2570

2002

  1. The regulation of microcin B, C and J operons

    Biochimie, Vol. 84, Núm. 5-6, pp. 521-529

  2. Very low cefotaxime concentrations select for hypermutable Streptococcus pneumoniae populations

    Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 2, pp. 528-530

1998

  1. An extended-spectrum AmpC-type β-lactamase obtained by in vitro antibiotic selection

    FEMS Microbiology Letters, Vol. 165, Núm. 1, pp. 85-90